Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Data from Ephrin-B3 Ligand Promotes Glioma Invasion through Activation of Rac1

View through CrossRef
<div>Abstract<p>Eph receptor tyrosine kinases are involved in nervous system development. Eph ligands, termed ephrins, are transmembrane proteins that bind to Eph receptors, the mutual activation of which causes repulsive effects in reciprocally contacting cells. Previously, we showed that overexpression of EphB2 in glioma cells increases cell invasion. Here, expression profiles of ephrin-B family members were determined in four glioma cell lines and in invading glioblastoma cells collected by laser capture microdissection. Ephrin-B3 mRNA was up-regulated in migrating cells of four of four glioma cell lines (1.3- to 1.7-fold) and in invading tumor cells of eight of eight biopsy specimens (1.2- to 10.0-fold). Forced expression of ephrin-B3 in low expressor cell lines (U87, T98G) stimulated cell migration and invasion <i>in vitro</i> and <i>ex vivo</i>, concomitant with tyrosine phosphorylation of ephrin-B3. In high expressor cell lines (U251, SNB19), ephrin-B3 colocalized with Rac1 to lamellipodia of motile wild-type cells. Cells transfected with ephrin-B3 small interfering RNA (siRNA) showed significant morphologic change and decreased invasion <i>in vitro</i> and <i>ex vivo</i>. Depletion of endogenous ephrin-B3 expression abrogated the increase of migration and invasion induced by EphB2/Fc, indicating increased invasion is dependent on ephrin-B3 activation. Furthermore, using a Rac1-GTP pull-down assay, we showed that ephrin-B3 is associated with Rac1 activation. Reduction of Rac1 by siRNA negated the increased invasion by addition of EphB2/Fc. In human glioma specimens, ephrin-B3 expression and phosphorylation correlated with increasing tumor grade. Immunohistochemistry revealed robust staining for phosphorylated ephrin-B and ephrin-B3 in invading glioblastoma cells. These data show that ephrin-B3 expression and signaling through Rac1 are critically important to glioma invasion. (Cancer Res 2006; 66(17): 8492-500)</p></div>
Title: Data from Ephrin-B3 Ligand Promotes Glioma Invasion through Activation of Rac1
Description:
<div>Abstract<p>Eph receptor tyrosine kinases are involved in nervous system development.
Eph ligands, termed ephrins, are transmembrane proteins that bind to Eph receptors, the mutual activation of which causes repulsive effects in reciprocally contacting cells.
Previously, we showed that overexpression of EphB2 in glioma cells increases cell invasion.
Here, expression profiles of ephrin-B family members were determined in four glioma cell lines and in invading glioblastoma cells collected by laser capture microdissection.
Ephrin-B3 mRNA was up-regulated in migrating cells of four of four glioma cell lines (1.
3- to 1.
7-fold) and in invading tumor cells of eight of eight biopsy specimens (1.
2- to 10.
0-fold).
Forced expression of ephrin-B3 in low expressor cell lines (U87, T98G) stimulated cell migration and invasion <i>in vitro</i> and <i>ex vivo</i>, concomitant with tyrosine phosphorylation of ephrin-B3.
In high expressor cell lines (U251, SNB19), ephrin-B3 colocalized with Rac1 to lamellipodia of motile wild-type cells.
Cells transfected with ephrin-B3 small interfering RNA (siRNA) showed significant morphologic change and decreased invasion <i>in vitro</i> and <i>ex vivo</i>.
Depletion of endogenous ephrin-B3 expression abrogated the increase of migration and invasion induced by EphB2/Fc, indicating increased invasion is dependent on ephrin-B3 activation.
Furthermore, using a Rac1-GTP pull-down assay, we showed that ephrin-B3 is associated with Rac1 activation.
Reduction of Rac1 by siRNA negated the increased invasion by addition of EphB2/Fc.
In human glioma specimens, ephrin-B3 expression and phosphorylation correlated with increasing tumor grade.
Immunohistochemistry revealed robust staining for phosphorylated ephrin-B and ephrin-B3 in invading glioblastoma cells.
These data show that ephrin-B3 expression and signaling through Rac1 are critically important to glioma invasion.
(Cancer Res 2006; 66(17): 8492-500)</p></div>.

Related Results

The Small GTPase Rac1 Increases Cell Surface Stiffness and Enhances 3D Migration Into Extracellular Matrices
The Small GTPase Rac1 Increases Cell Surface Stiffness and Enhances 3D Migration Into Extracellular Matrices
AbstractMembrane ruffling and lamellipodia formation promote the motility of adherent cells in two-dimensional motility assays by mechano-sensing of the microenvironment and initia...
Abstract 432: The noncanonical mechanism of metabolic enzyme LDHA in cancer progression
Abstract 432: The noncanonical mechanism of metabolic enzyme LDHA in cancer progression
Abstract Metabolic reprogramming is a hallmark of cancer cells and a key contributor to cancer progression, which is a promising target for cancer therapies. The enh...
FRET and LRET Biosensors for Cell-based Imaging and Screening of Rac1 Activation
FRET and LRET Biosensors for Cell-based Imaging and Screening of Rac1 Activation
ABSTRACT Rac1 is a key regulator of several cell signaling pathways and dysregulated Rac1 activation has been implicated in cancer. Genetically e...
Rac1 Signaling: From Intestinal Homeostasis to Colorectal Cancer Metastasis
Rac1 Signaling: From Intestinal Homeostasis to Colorectal Cancer Metastasis
The small GTPase Rac1 has been implicated in a variety of dynamic cell biological processes, including cell proliferation, cell survival, cell-cell contacts, epithelial mesenchymal...
PLEKHA4 is a prognostic biomarker and correlated with immune infiltrates in glioma
PLEKHA4 is a prognostic biomarker and correlated with immune infiltrates in glioma
Abstract Background Gliomas are the most common and life-threatening intracranial tumors. Immune-infiltration of the tumor microenvironment significantly affects tumor pro...
Abstract 1229: Neoadjuvant therapy alters collagen architecture of pancreatic cancer
Abstract 1229: Neoadjuvant therapy alters collagen architecture of pancreatic cancer
Abstract Treatment of pancreatic cancer remains clinically challenging and requires the novel therapeutic interventions to improve patient outcome. Neoadjuvant th...

Back to Top